Andrew A. Lukowiak's most recent trade in Talis Biomedical Corp was a trade of 30,575 Stock option (right to buy) done . Disclosure was reported to the exchange on Aug. 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Talis Biomedical Corp | Andrew A. Lukowiak | President, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 30,575 | 30,575 | - | - | Stock option (right to buy) |